AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
CHIMERIC INTERLEUKIN-2 RECEPTORS FOR THE ACTIVATION OF LYMPHOCYTES
Authors: TEITZ S WAKS T SCHINDLER D ESHHAR Z
Citation: S. Teitz et al., CHIMERIC INTERLEUKIN-2 RECEPTORS FOR THE ACTIVATION OF LYMPHOCYTES, European cytokine network, 9(3), 1998, pp. 510-510
TYROSINE KINASE CHIMERAS FOR ANTIGEN-SELECTIVE T-BODY THERAPY
Authors: FITZERATTAS CJ ESHHAR Z
Citation: Cj. Fitzerattas et Z. Eshhar, TYROSINE KINASE CHIMERAS FOR ANTIGEN-SELECTIVE T-BODY THERAPY, Advanced drug delivery reviews, 31(1-2), 1998, pp. 171-182
HARNESSING SYK FAMILY TYROSINE KINASES AS SIGNALING DOMAINS FOR CHIMERIC SINGLE-CHAIN OF THE VARIABLE DOMAIN RECEPTORS - OPTIMAL-DESIGN FORT-CELL ACTIVATION
Authors: FITZERATTAS CJ SCHINDLER DG WAKS T ESHHAR Z
Citation: Cj. Fitzerattas et al., HARNESSING SYK FAMILY TYROSINE KINASES AS SIGNALING DOMAINS FOR CHIMERIC SINGLE-CHAIN OF THE VARIABLE DOMAIN RECEPTORS - OPTIMAL-DESIGN FORT-CELL ACTIVATION, The Journal of immunology, 160(1), 1998, pp. 145-154
TARGETING OF INTERLEUKIN-2 TO HUMAN OVARIAN-CARCINOMA BY FUSION WITH A SINGLE-CHAIN FV OF ANTIFOLATE RECEPTOR ANTIBODY
Authors: MELANI C FIGINI M NICOSIA D LUISON E RAMAKRISHNA V CASORATI G PARMIANI G ESHHAR Z CANEVARI S COLOMBO MP
Citation: C. Melani et al., TARGETING OF INTERLEUKIN-2 TO HUMAN OVARIAN-CARCINOMA BY FUSION WITH A SINGLE-CHAIN FV OF ANTIFOLATE RECEPTOR ANTIBODY, Cancer research, 58(18), 1998, pp. 4146-4154
THE T-BODY APPROACH FOR CANCER GENE-THERAPY
Authors: ESHHAR Z
Citation: Z. Eshhar, THE T-BODY APPROACH FOR CANCER GENE-THERAPY, Cancer gene therapy, 4(5), 1997, pp. 321-322
TUMOR-SPECIFIC T-BODIES - TOWARDS CLINICAL-APPLICATION
Authors: ESHHAR Z
Citation: Z. Eshhar, TUMOR-SPECIFIC T-BODIES - TOWARDS CLINICAL-APPLICATION, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 131-136
EXPRESSION AND CHARACTERIZATION OF RECOMBINANT SINGLE-CHAIN FV AND FVFRAGMENTS DERIVED FROM A SET OF CATALYTIC ANTIBODIES
Authors: KIM SH SCHINDLER DG LINDNER AB TAWFIK DS ESHHAR Z
Citation: Sh. Kim et al., EXPRESSION AND CHARACTERIZATION OF RECOMBINANT SINGLE-CHAIN FV AND FVFRAGMENTS DERIVED FROM A SET OF CATALYTIC ANTIBODIES, Molecular immunology, 34(12-13), 1997, pp. 891-906
COMBINING THE INTRACELLULAR TYROSINE KINASE SYK WITH EXTRACELLULAR SCFV FOR T-CELL ACTIVATION
Authors: FITZERATTAS CJ SCHINDLER DG WAKS T ESHHAR Z
Citation: Cj. Fitzerattas et al., COMBINING THE INTRACELLULAR TYROSINE KINASE SYK WITH EXTRACELLULAR SCFV FOR T-CELL ACTIVATION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 170-170
STRUCTURAL CONVERGENCE IN THE ACTIVE-SITES OF A FAMILY OF CATALYTIC ANTIBODIES
Authors: CHARBONNIER JB GOLINELLIPIMPANEAU B GIGANT B TAWFIK DS CHAP R SCHINDLER DG KIM SH GREEN BS ESHHAR Z KNOSSOW M
Citation: Jb. Charbonnier et al., STRUCTURAL CONVERGENCE IN THE ACTIVE-SITES OF A FAMILY OF CATALYTIC ANTIBODIES, Science, 275(5303), 1997, pp. 1140-1142
X-RAY STRUCTURES OF A HYDROLYTIC ANTIBODY AND OF COMPLEXES ELUCIDATE CATALYTIC PATHWAY FROM SUBSTRATE-BINDING AND TRANSITION-STATE STABILIZATION THROUGH WATER ATTACK AND PRODUCT RELEASE
Authors: GIGANT B CHARBONNIER JB ESHHAR Z GREEN BS KNOSSOW M
Citation: B. Gigant et al., X-RAY STRUCTURES OF A HYDROLYTIC ANTIBODY AND OF COMPLEXES ELUCIDATE CATALYTIC PATHWAY FROM SUBSTRATE-BINDING AND TRANSITION-STATE STABILIZATION THROUGH WATER ATTACK AND PRODUCT RELEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(15), 1997, pp. 7857-7861
DIRECT T-CELL ACTIVATION BY CHIMERIC SINGLE-CHAIN FV-SYK PROMOTES SYK-CBL ASSOCIATION AND CBL PHOSPHORYLATION
Authors: FITZERATTAS CJ SCHINDLER DG WAKS T ESHHAR Z
Citation: Cj. Fitzerattas et al., DIRECT T-CELL ACTIVATION BY CHIMERIC SINGLE-CHAIN FV-SYK PROMOTES SYK-CBL ASSOCIATION AND CBL PHOSPHORYLATION, The Journal of biological chemistry, 272(13), 1997, pp. 8551-8557
MECHANISM OF INACTIVATION OF A CATALYTIC ANTIBODY BY P-NITROPHENYL ESTERS
Authors: GIGANT B CHARBONNIER JB GOLINELLIPIMPANEAU B ZEMEL RR ESHHAR Z GREEN BS KNOSSOW M
Citation: B. Gigant et al., MECHANISM OF INACTIVATION OF A CATALYTIC ANTIBODY BY P-NITROPHENYL ESTERS, European journal of biochemistry, 246(2), 1997, pp. 471-476
EFFICIENT AND SELECTIVE P-NITROPHENYL-ESTER-HYDROLYZING ANTIBODIES ELICITED BY A P-NITROBENZYL PHOSPHONATE HAPTEN
Authors: TAWFIK DS LINDNER AB CHAP R ESHHAR Z GREEN BS
Citation: Ds. Tawfik et al., EFFICIENT AND SELECTIVE P-NITROPHENYL-ESTER-HYDROLYZING ANTIBODIES ELICITED BY A P-NITROBENZYL PHOSPHONATE HAPTEN, European journal of biochemistry, 244(2), 1997, pp. 619-626
REDIRECTING EFFECTOR LYMPHOCYTES USING CHIMERIC RECEPTORS WITH ANTIBODY SPECIFICITY - NEW APPROACH FOR IMMUNO-GENE THERAPY OF CANCER
Authors: ESHHAR Z WAKS T GROSS G LUSTGARTEN J BACH N FITZERATTAS CJ RATNER A SCHINDLER DG
Citation: Z. Eshhar et al., REDIRECTING EFFECTOR LYMPHOCYTES USING CHIMERIC RECEPTORS WITH ANTIBODY SPECIFICITY - NEW APPROACH FOR IMMUNO-GENE THERAPY OF CANCER, Journal of clinical biochemistry and nutrition, 21(1), 1996, pp. 86-87
THE T-BODY APPROACH - POTENTIAL FOR CANCER-IMMUNOTHERAPY
Authors: ESHHAR Z BACH N FITZERATTAS CJ GROSS G LUSTGARTEN J WAKS T SCHINDLER DG
Citation: Z. Eshhar et al., THE T-BODY APPROACH - POTENTIAL FOR CANCER-IMMUNOTHERAPY, Perspectives in mathematical logic, 18(2), 1996, pp. 199-209
PROLONGED INHIBITION OF IGE PRODUCTION IN MICE FOLLOWING TREATMENT WITH AN IGE-SPECIFIC IMMUNOTOXIN
Authors: LUSTGARTEN J WAKS T ESHHAR Z
Citation: J. Lustgarten et al., PROLONGED INHIBITION OF IGE PRODUCTION IN MICE FOLLOWING TREATMENT WITH AN IGE-SPECIFIC IMMUNOTOXIN, Molecular immunology, 33(3), 1996, pp. 245-251
TARGETING T-CELLS TO CANCER USING CHIMERIC RECEPTORS
Authors: ESHHAR Z WAKS T FITZERATTAS CJ FEIGELSON S TEITZ S SCHINDLER DG
Citation: Z. Eshhar et al., TARGETING T-CELLS TO CANCER USING CHIMERIC RECEPTORS, Immunology, 89, 1996, pp. 114-114
CHIMERIC T-CELL RECEPTORS SPECIFIC TO A B-LYMPHOMA IDIOTYPE - A MODELFOR TUMOR-IMMUNOTHERAPY
Authors: GROSS G LEVY S LEVY R WAKS T ESHHAR Z
Citation: G. Gross et al., CHIMERIC T-CELL RECEPTORS SPECIFIC TO A B-LYMPHOMA IDIOTYPE - A MODELFOR TUMOR-IMMUNOTHERAPY, Biochemical Society transactions, 23(4), 1995, pp. 1079-1082
UNEXPECTEDLY HIGH OCCURRENCE OF CATALYTIC ANTIBODIES IN MRL LPR AND SJL MICE IMMUNIZED WITH A TRANSITION-STATE ANALOG - IS THERE A LINKAGE TO AUTOIMMUNITY/
Authors: TAWFIK DS CHAP R GREEN BS SELA M ESHHAR Z
Citation: Ds. Tawfik et al., UNEXPECTEDLY HIGH OCCURRENCE OF CATALYTIC ANTIBODIES IN MRL LPR AND SJL MICE IMMUNIZED WITH A TRANSITION-STATE ANALOG - IS THERE A LINKAGE TO AUTOIMMUNITY/, Proceedings of the National Academy of Sciences of the United Statesof America, 92(6), 1995, pp. 2145-2149
CRYSTAL-STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB FRAGMENTWITH A TRANSITION-STATE ANALOG - STRUCTURAL SIMILARITIES IN ESTERASE-LIKE CATALYTIC ANTIBODIES
Authors: CHARBONNIER JB CARPENTER E GIGANT B GOLINELLIPIMPANEAU B ESHHAR Z GREEN BS KNOSSOW M
Citation: Jb. Charbonnier et al., CRYSTAL-STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB FRAGMENTWITH A TRANSITION-STATE ANALOG - STRUCTURAL SIMILARITIES IN ESTERASE-LIKE CATALYTIC ANTIBODIES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(25), 1995, pp. 11721-11725
SPECIFIC ELIMINATION OF IGE PRODUCTION USING T-CELL LINES EXPRESSING CHIMERIC T-CELL RECEPTOR GENES
Authors: LUSTGARTEN J ESHHAR Z
Citation: J. Lustgarten et Z. Eshhar, SPECIFIC ELIMINATION OF IGE PRODUCTION USING T-CELL LINES EXPRESSING CHIMERIC T-CELL RECEPTOR GENES, European Journal of Immunology, 25(10), 1995, pp. 2985-2991
IN-VIVO ANTITUMOR-ACTIVITY OF T-CELLS REDIRECTED WITH CHIMERIC ANTIBODY T-CELL RECEPTOR GENES
Authors: HWU P YANG JC COWHERD R TREISMAN J SHAFER GE ESHHAR Z ROSENBERG SA
Citation: P. Hwu et al., IN-VIVO ANTITUMOR-ACTIVITY OF T-CELLS REDIRECTED WITH CHIMERIC ANTIBODY T-CELL RECEPTOR GENES, Cancer research, 55(15), 1995, pp. 3369-3373
CRYSTAL-STRUCTURE OF A CATALYTIC ANTIBODY FAB WITH ESTERASE-LIKE ACTIVITY
Authors: GOLINELLIPIMPANEAU B GIGANT B BIZEBARD T NAVAZA J SALUDJIAN P ZEMEL R TAWFIK DS ESHHAR Z GREEN BS KNOSSOW M
Citation: B. Golinellipimpaneau et al., CRYSTAL-STRUCTURE OF A CATALYTIC ANTIBODY FAB WITH ESTERASE-LIKE ACTIVITY, Structure, 2(3), 1994, pp. 175-183
PH ON-OFF SWITCHING OF ANTIBODY HAPTEN BINDING BY SITE-SPECIFIC CHEMICAL MODIFICATION OF TYROSINE
Authors: TAWFIK DS CHAP R ESHHAR Z GREEN BS
Citation: Ds. Tawfik et al., PH ON-OFF SWITCHING OF ANTIBODY HAPTEN BINDING BY SITE-SPECIFIC CHEMICAL MODIFICATION OF TYROSINE, Protein engineering, 7(3), 1994, pp. 431-434
DIFFERENCES IN THE BIOCHEMICAL-PROPERTIES OF ESTEROLYTIC ANTIBODIES CORRELATE WITH STRUCTURAL DIVERSITY
Authors: ZEMEL R SCHINDLER DG TAWFIK DS ESHHAR Z GREEN BS
Citation: R. Zemel et al., DIFFERENCES IN THE BIOCHEMICAL-PROPERTIES OF ESTEROLYTIC ANTIBODIES CORRELATE WITH STRUCTURAL DIVERSITY, Molecular immunology, 31(2), 1994, pp. 127-137
Risultati: 1-25 | 26-33